
MISSION Therapeutics, a drug discovery and development company today has appointed Dr Colin Goddard, former chief executive of OSI Pharmaceuticals, …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

